ATE138930T1 - 4-substitutiertes 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase - Google Patents

4-substitutiertes 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase

Info

Publication number
ATE138930T1
ATE138930T1 AT90115390T AT90115390T ATE138930T1 AT E138930 T1 ATE138930 T1 AT E138930T1 AT 90115390 T AT90115390 T AT 90115390T AT 90115390 T AT90115390 T AT 90115390T AT E138930 T1 ATE138930 T1 AT E138930T1
Authority
AT
Austria
Prior art keywords
beta
androst
cyclopropyloxy
substituted
lyase
Prior art date
Application number
AT90115390T
Other languages
English (en)
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE138930T1 publication Critical patent/ATE138930T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT90115390T 1989-08-15 1990-08-10 4-substitutiertes 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase ATE138930T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,026 US4966897A (en) 1989-08-15 1989-08-15 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Publications (1)

Publication Number Publication Date
ATE138930T1 true ATE138930T1 (de) 1996-06-15

Family

ID=23557245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90115390T ATE138930T1 (de) 1989-08-15 1990-08-10 4-substitutiertes 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase

Country Status (22)

Country Link
US (1) US4966897A (de)
EP (1) EP0413269B1 (de)
JP (1) JP2879702B2 (de)
KR (1) KR910004650A (de)
CN (1) CN1050195A (de)
AT (1) ATE138930T1 (de)
AU (1) AU628210B2 (de)
CA (1) CA2023008C (de)
DD (1) DD298106A5 (de)
DE (1) DE69027262T2 (de)
DK (1) DK0413269T3 (de)
ES (1) ES2090064T3 (de)
FI (1) FI95711C (de)
GR (1) GR3020797T3 (de)
HU (1) HUT55030A (de)
IE (1) IE902941A1 (de)
IL (1) IL95359A (de)
NO (1) NO903565L (de)
NZ (1) NZ234855A (de)
PH (1) PH27549A (de)
PT (1) PT94994B (de)
ZA (1) ZA906307B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
WO1994020520A1 (en) * 1993-03-10 1994-09-15 Magainin Pharmaceuticals Inc. Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
PT910382E (pt) * 1996-04-26 2003-10-31 Genaera Corp Esqualamina em combinacao com outros agentes anti-cancro para o tratamento de tumores
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
DK1274718T3 (da) * 2000-04-12 2007-02-12 Genaera Corp En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe
JP2007297879A (ja) * 2006-05-02 2007-11-15 Central Glass Co Ltd 電磁波吸収板

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475464A (en) * 1966-11-07 1969-10-28 Syntex Corp Process for the preparation of steroids and novel intermediates thereof
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
DE69027262D1 (de) 1996-07-11
AU6087890A (en) 1991-02-21
HUT55030A (en) 1991-04-29
IL95359A (en) 1995-08-31
NZ234855A (en) 1992-11-25
DK0413269T3 (da) 1996-06-24
FI95711B (fi) 1995-11-30
PT94994B (pt) 1997-05-28
DD298106A5 (de) 1992-02-06
US4966897A (en) 1990-10-30
EP0413269A3 (en) 1992-05-20
FI95711C (fi) 1996-03-11
AU628210B2 (en) 1992-09-10
PT94994A (pt) 1991-04-18
HU905005D0 (en) 1991-01-28
FI904036A0 (fi) 1990-08-15
JPH0383996A (ja) 1991-04-09
KR910004650A (ko) 1991-03-29
CA2023008C (en) 2001-05-15
NO903565D0 (no) 1990-08-14
ES2090064T3 (es) 1996-10-16
CA2023008A1 (en) 1991-02-16
PH27549A (en) 1993-08-18
EP0413269A2 (de) 1991-02-20
IE902941A1 (en) 1991-02-27
IL95359A0 (en) 1991-06-30
ZA906307B (en) 1991-06-26
GR3020797T3 (en) 1996-11-30
NO903565L (no) 1991-02-18
DE69027262T2 (de) 1996-10-02
JP2879702B2 (ja) 1999-04-05
CN1050195A (zh) 1991-03-27
EP0413269B1 (de) 1996-06-05

Similar Documents

Publication Publication Date Title
DE69027262D1 (de) 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase
ATE137761T1 (de) 4-substituiertes 17-beta-(cyclopropyl-amino)- androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase
ATE91684T1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
DK0721455T3 (da) Tetrahydropyridin-(eller 4-hydroxypiperidin)alkylazoler med en affinitet for sigma og/eller 5-HT1A-receptorer
DE3864725D1 (de) C17-20-lyase-inhibitoren.
HU9203761D0 (en) Method for producing substituted pyridine derivatives
DE3872938D1 (de) 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol-derivate und verwandte verbindungen als c17-20 lyase-inhibitoren.
ATE131061T1 (de) Förderung der osteogenese durch verwendung von vitamin d-derivaten.
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
FR2552429B1 (fr) Procede de preparation de quinolinones-4

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee